TE T1 Energy Inc. Common Stock
$8,46
Fiyat · Haz 26, 2026
Temel veriler itibarıyla May 12, 2026
52 Haftlık Aralık
$1–$12
64% of range
Analist Derecelendirmesi
BUY
13 analysts
Fiyat Hedefi
$10
+19% upside
P/E (TTM)
-3.1
ROE
—
Net Kâr Marjı
—
TE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$8.46
Piyasa Değeri
—
P/E (TTM)
-3.1
EPS (TTM)
$-2.19
Gelir (TTM)
$755M
Temettü Verimi
—
ROE
—
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $12
TE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$755M
2023-12-31
→
2025-12-31
Hisse Başına Kâr
$-2.19
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
—
2023-12-31
→
2023-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
TE
Akran Ortalaması
P/E (TTM)
-3.1
27.2
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
TE
Akran Ortalaması
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
TE
Akran Ortalaması
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
TE
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
25572.8%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
TE
Akran Ortalaması
TE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
13 analist
- Güçlü Al 4 30,8%
- Al 8 61,5%
- Tut 1 7,7%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
7 analist · 2026-06-26
Medyan
$9.00
Ortalama
$10.07
Şimdi
$8.46
Düşük
$8.00
Yüksek
$16.00
Medyan hedef
$9.00
+6,4%
Ortalama hedef
$10.07
+19,0%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.25%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.08 | $-0.16 | 0.08% |
| 31 Aralık 2025 | $-0.83 | $0.01 | -0.84% |
| 30 Eylül 2025 | $-0.51 | $-0.12 | -0.39% |
| 30 Haziran 2025 | $-0.21 | $-0.13 | -0.08% |
| 31 Mart 2025 | $-0.11 | $-0.07 | -0.04% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TE | — | -3.1 | 25572.8% | — | — | — |
| FLNC | — | -29.2 | -16.2% | -2.1% | -10.7% | 13.1% |
| PLUG | — | -1.4 | 12.9% | -229.8% | -120.3% | -34.1% |
| RUN | $4.30B | 10.8 | 45.1% | 15.2% | 15.8% | — |
| ATKR | $2.11B | -139.4 | -11.0% | -0.53% | -1.1% | 23.7% |
| EOSE | $3.86B | -1.7 | 631.8% | -849.1% | 58.0% | -126.0% |
| AMSC | $1.61B | 11.1 | 34.3% | 44.7% | 29.8% | 30.6% |
| PLPC | $1.01B | 29.0 | 12.7% | 5.3% | 7.9% | 31.2% |
| AMPX | $1.06B | -22.5 | 202.1% | -60.3% | -48.8% | 11.3% |
| ALNT | $910M | 40.7 | 4.6% | 4.0% | 7.5% | 32.8% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $755M | $3M | $0 | |
| Cost of Revenue | $700M | $2M | $0 | |
| Gross Profit | $56M | $1M | $0 | |
| R&D Expense | · | · | $28M | |
| SG&A Expense | $235M | $79M | $66M | |
| Operating Expenses | $290M | $80M | $143M | |
| Operating Income | $-235M | $-79M | $-66M | |
| Other Non-op | $1M | $9M | $6M | |
| Pretax Income | $-341M | $-83M | $-18M | |
| Income Tax | $-19M | $-16M | $443.0K | |
| Net Income | $-368M | $-451M | $-73M | |
| EPS (Basic) | $-2.19 | $-3.20 | $-0.51 | |
| EPS (Diluted) | $-2.19 | $-3.20 | $-0.51 | |
| Shares (Basic) | 173,640,000 | 140,538,000 | 139,705,000 | |
| Shares (Diluted) | 173,640,000 | 140,538,000 | 139,705,000 | |
| EBITDA | · | · | $-140M |
Bilanço 28
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $182M | $73M | $253M | |
| Receivables | $84M | $0 | · | |
| Inventory | $116M | $275M | $0 | |
| Prepaid Expense | · | · | $2M | |
| Other Current Assets | $6M | $4M | $0 | |
| Current Assets | $663M | $572M | $312M | |
| PP&E (Net) | $302M | $294M | $2M | |
| PP&E (Gross) | $347M | $306M | $3M | |
| Accum. Depreciation | $45M | $12M | $1M | |
| Goodwill | $57M | $75M | $0 | |
| Intangibles | $180M | $284M | $3M | |
| Other Non-current Assets | $10M | $0 | $4M | |
| Total Assets | $1.37B | $1.34B | $732M | |
| Accounts Payable | · | · | $18M | |
| Accrued Liabilities | $47M | $93M | $10M | |
| Current Liabilities | $464M | $410M | $49M | |
| Capital Leases | $144M | $106M | $0 | |
| Deferred Tax | $4M | $21M | $443.0K | |
| Other Non-current Liabilities | $47M | $22M | $2M | |
| Total Liabilities | $1.05B | $1.10B | $97M | |
| Long-term Debt | $390M | $602M | $0 | |
| Common Stock | $3M | $2M | $1M | |
| Paid-in Capital | $1.36B | $971M | $926M | |
| Retained Earnings | $-1.09B | $-725M | $-275M | |
| AOCI | $-18M | $-59M | $-19M | |
| Stockholders' Equity | $250M | $189M | $635M | |
| Liabilities + Equity | $1.37B | $1.34B | $732M | |
| Shares Outstanding | 266,267,000 | 155,928,000 | 139,705,000 |
Nakit Akışı 15
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $93M | $10M | $3M | |
| Stock-based Comp | $11M | $8M | $12M | |
| Deferred Tax | $-20M | $-16M | $443.0K | |
| Amort. of Intangibles | $48M | $1M | $0 | |
| Restructuring | · | · | $6M | |
| Other Non-cash | · | · | $-31M | |
| Operating Cash Flow | $95M | $-103M | $-88M | |
| CapEx | $79M | $51M | $188M | |
| Investing Cash Flow | $-33M | $-138M | $-187M | |
| Stock Issued | · | · | $0 | |
| Net Stock Activity | · | · | $0 | |
| Financing Cash Flow | $130M | $46M | $0 | |
| Net Change in Cash | $194M | $-199M | $-287M | |
| Taxes Paid | $10.0K | $21.0K | · | |
| Free Cash Flow | · | · | $-276M |
Kârlılık 3
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | · | · | -9.2% | |
| ROE | · | · | -10.7% | |
| ROIC | · | · | -22.8% |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | · | · | 6.3 | |
| Quick Ratio | · | · | 5.2 |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 25572.8% | · | · |
Değerleme (TTM) 9
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $755M | $3M | $0 | |
| Net Income TTM | $-368M | $-451M | $-73M | |
| Market Cap | · | · | $261M | |
| P/E | -3.1 | -0.8 | -3.7 | |
| P/B | · | · | 0.4 | |
| P / Tangible Book | 143.0 | · | 0.4 | |
| P / Cash Flow | · | · | -3.0 | |
| P / FCF | · | · | -0.9 | |
| Earnings Yield | -32.8% | -124.0% | -27.3% |
Gelir Tablosu 16
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $178M | $359M | $211M | $133M | $53M | $3M | $0 | $0 | $0 | |
| Cost of Revenue | $149M | $375M | $189M | $100M | $36M | $2M | $0 | $0 | $0 | |
| Gross Profit | $29M | $-16M | $21M | $33M | $18M | $1M | $0 | $0 | $0 | |
| R&D Expense | · | · | · | · | · | · | $9M | $10M | $12M | |
| SG&A Expense | $52M | $69M | $63M | $62M | $43M | $33M | $17M | $14M | $15M | |
| Operating Expenses | $52M | $71M | $116M | · | $43M | $-3M | $17M | $31M | $35M | |
| Operating Income | $-23M | $-87M | $-95M | $-29M | $-26M | $-33M | $-17M | $-14M | $-15M | |
| Other Non-op | $2M | $3M | $-377.0K | $-1M | $163.0K | $4M | $1M | $2M | $2M | |
| Pretax Income | $4M | $-157M | $-140M | $-38M | $-9M | $-47M | $-14M | $-10M | $-11M | |
| Income Tax | $-222.0K | $1M | $-12M | $-6M | $-3M | $-16M | $0 | $11.0K | $0 | |
| Net Income | $-20M | $-189M | $-131M | $-32M | $-16M | $-367M | $-28M | $-27M | $-29M | |
| EPS (Basic) | $-0.08 | $-1.00 | $-0.87 | $-0.21 | $-0.11 | $-2.61 | $-0.20 | $-0.19 | $-0.20 | |
| EPS (Diluted) | $-0.08 | $-1.00 | $-0.87 | $-0.21 | $-0.11 | $-2.61 | $-0.20 | $-0.19 | $-0.20 | |
| Shares (Basic) | 278,539,000 | -299,208,000 | 160,977,000 | 155,938,000 | 155,933,000 | -279,764,000 | 140,490,000 | 140,107,000 | 139,705,000 | |
| Shares (Diluted) | 285,252,000 | -299,208,000 | 160,977,000 | 155,938,000 | 155,933,000 | -279,764,000 | 140,490,000 | 140,107,000 | 139,705,000 | |
| EBITDA | $3M | · | $-95M | $-29M | $-9M | · | $-32M | $-31M | $-33M |
Bilanço 29
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $182M | $34M | $8M | $49M | $73M | $182M | $220M | $250M | |
| Receivables | $100M | $84M | · | · | · | $0 | · | · | · | |
| Inventory | $129M | $116M | $252M | $326M | $333M | $275M | · | · | · | |
| Prepaid Expense | · | · | · | · | · | · | $3M | $868.0K | $2M | |
| Other Current Assets | $10M | $6M | $204.0K | $2M | $8M | $4M | $13M | $12M | $14M | |
| Current Assets | $585M | $663M | $695M | $645M | $627M | $572M | $199M | $234M | $268M | |
| PP&E (Net) | $346M | $302M | $290M | $297M | $310M | $294M | $368M | $363M | $354M | |
| PP&E (Gross) | $405M | $347M | $323M | $317M | $315M | $306M | $379M | $371M | $360M | |
| Accum. Depreciation | $59M | $45M | $33M | $20M | $5M | $12M | $11M | $8M | $6M | |
| Goodwill | $57M | $57M | $61M | $61M | $75M | $75M | · | · | · | |
| Intangibles | $169M | $180M | $192M | $257M | $271M | $284M | $3M | $3M | $3M | |
| Other Non-current Assets | $10M | $10M | · | · | · | $0 | $10.0K | $9.0K | $9.0K | |
| Total Assets | $1.34B | $1.37B | $1.40B | $1.41B | $1.43B | $1.34B | $615M | $644M | $670M | |
| Accounts Payable | · | · | · | · | · | · | $10M | $15M | $8M | |
| Accrued Liabilities | $65M | $47M | $31M | $63M | $77M | $93M | $21M | $20M | $31M | |
| Current Liabilities | $466M | $464M | $616M | $512M | $493M | $410M | $31M | $35M | $40M | |
| Capital Leases | $154M | $144M | $141M | $140M | $140M | $106M | $17M | $17M | $17M | |
| Deferred Tax | $3M | $4M | $2M | $14M | $20M | $21M | · | · | · | |
| Other Non-current Liabilities | $26M | $47M | $26M | $8M | $10M | $22M | $27M | $27M | $27M | |
| Total Liabilities | $1.03B | $1.05B | $1.24B | $1.18B | $1.18B | $1.10B | $76M | $82M | $87M | |
| Long-term Debt | $378M | $390M | $547M | $591M | $603M | $602M | · | · | · | |
| Total Debt | $378M | · | $547M | $591M | $603M | · | · | · | · | |
| Common Stock | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Paid-in Capital | $1.36B | $1.36B | $1.01B | $975M | $975M | $971M | $929M | $931M | $929M | |
| Retained Earnings | $-1.11B | $-1.09B | $-904M | $-773M | $-741M | $-725M | $-358M | $-331M | $-304M | |
| AOCI | $-11M | $-18M | $-16M | $-19M | $-33M | $-59M | $-34M | $-40M | $-45M | |
| Stockholders' Equity | $237M | $250M | $97M | $184M | $202M | $189M | $539M | $562M | $582M | |
| Liabilities + Equity | $1.34B | $1.37B | $1.40B | $1.41B | $1.43B | $1.34B | $615M | $644M | $670M | |
| Shares Outstanding | 279,037,000 | 266,267,000 | 168,626,000 | 155,938,000 | 155,938,000 | 155,928,000 | 140,490,000 | 140,490,000 | 139,705,000 |
Nakit Akışı 13
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $25M | $25M | $25M | $29M | $15M | $3M | $2M | $2M | $2M | |
| Stock-based Comp | $3M | $4M | $2M | $1M | $4M | $1M | $1M | $1M | $4M | |
| Deferred Tax | · | $-622.0K | $-12M | $-6M | $-995.0K | $-16M | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | · | $11M | $11M | $1M | $38.0K | $37.0K | $0 | |
| Restructuring | · | · | · | · | · | · | $5M | · | · | |
| Other Non-cash | $-80M | · | · | · | $-46M | · | · | · | $7M | |
| Operating Cash Flow | $-73M | $43M | $64M | $33M | $-45M | $-30M | $-28M | $-28M | $-16M | |
| CapEx | $61M | $18M | $9M | $23M | $29M | $16M | $6M | $8M | $21M | |
| Investing Cash Flow | $-61M | $-23M | $-9M | $-23M | $22M | $-126M | $-6M | $-4M | $-2M | |
| Financing Cash Flow | $-14M | $163M | $-15M | $-15M | $-4M | $50M | $-4M | $0 | $0 | |
| Net Change in Cash | $-147M | $184M | $40M | $-4M | $-26M | $-107M | $-37M | $-31M | $-23M | |
| Taxes Paid | $0 | $10.0K | · | · | $0 | $21.0K | · | · | · | |
| Free Cash Flow | $-134M | · | · | · | $-74M | · | · | · | $-38M |
Kârlılık 8
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 16.4% | · | 10.1% | 24.7% | 33.3% | · | · | · | · | |
| Operating Margin | -12.7% | · | -45.0% | -22.0% | -44.2% | · | · | · | · | |
| Net Margin | -11.5% | · | -62.0% | -24.0% | -30.4% | · | · | · | · | |
| Pretax Margin | 2.1% | · | -66.3% | -28.5% | -12.4% | · | · | · | · | |
| EBITDA Margin | 1.5% | · | -45.0% | -22.0% | -16.7% | · | · | · | · | |
| ROA | -1.5% | · | -13.0% | -3.1% | -1.6% | · | -8.9% | -8.4% | -8.5% | |
| ROE | -9.3% | · | -41.1% | -8.6% | -4.1% | · | -10.2% | -9.6% | -9.8% | |
| ROIC | -3.9% | · | -13.4% | -3.2% | -1.8% | · | -5.9% | -5.5% | -6.0% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | · | 1.1 | 1.3 | 1.3 | · | 6.4 | 6.6 | 6.7 | |
| Quick Ratio | 0.3 | · | 0.1 | 0.0 | 0.1 | · | 5.8 | 6.2 | 6.2 | |
| Debt / Equity | 1.6 | · | 5.6 | 3.2 | 3.0 | · | · | · | · | |
| LT Debt / Equity | 1.4 | · | 4.4 | 2.6 | 2.4 | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | · | · | · | |
| Inventory Turnover | 0.6 | · | 1.5 | 0.6 | 0.2 | · | · | · | · | |
| Receivables Turnover | 3.6 | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $574M | · | $397M | $186M | $53M | · | · | · | · | |
| Net Income TTM | $-199M | · | $-206M | $-103M | $-100M | · | $-93M | $-91M | $-76M | |
| Market Cap | $1.22B | · | $368M | $192M | $196M | · | $136M | $239M | $235M | |
| Enterprise Value | $1.56B | · | $881M | $775M | $751M | · | · | · | · | |
| P/E | -3.5 | · | -1.6 | -1.7 | -1.8 | · | -1.5 | -2.7 | -3.1 | |
| P/S | 2.1 | · | 0.9 | 1.0 | 3.7 | · | · | · | · | |
| P/B | 5.2 | · | 3.8 | 1.0 | 1.0 | · | 0.3 | 0.4 | 0.4 | |
| P / Tangible Book | 121.0 | · | · | · | · | · | 0.3 | 0.4 | 0.4 | |
| P / Cash Flow | -16.8 | · | · | · | -4.4 | · | · | · | -14.5 | |
| P / FCF | -9.2 | · | · | · | -2.7 | · | · | · | -6.2 | |
| EV / EBITDA | 598.9 | · | -9.3 | -26.5 | -84.0 | · | · | · | · | |
| EV / FCF | -11.7 | · | · | · | -10.2 | · | · | · | · | |
| EV / Revenue | 2.7 | · | 2.2 | 4.2 | 14.0 | · | · | · | · | |
| Earnings Yield | -28.9% | · | -63.8% | -57.7% | -55.6% | · | -68.0% | -37.6% | -32.1% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $755M | $3M | $0 | — | — |
| Net Gelir | $-368M | $-451M | $-73M | $-99M | $-93M |
| Seyreltilmiş Hisse Başı Kâr | $-2.19 | $-3.20 | $-0.51 | $-0.83 | $-1.24 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | — | — | 6.3 | — | — |
| Cari Oran | — | — | 5.2 | — | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | — | — | $-276M | — | — |
Son Haberler Bu şirketten bahseden son manşetler
- Sanofi: EC Approves Sarclisa SC For Multiple Myeloma, First EU Therapy Via On-Body Injector
- T1 Energy (TE) Powers to 3-Year High on Strong Q2 Hopes
- T1 Energy (TE) Soars to 4-Year High as Chinese Investors Dispose of Stake
- Roth Capital, T1 Energy (TE) Sonrası Son Tartışmaların Ardından Derecelendirmesini Yineledi
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.